Molecular genetics of attention-deficit hyperactivity disorder

Key Issues in Mental Health

Volumn 176, Issue , 2010, Pages 58-77

  Retz, Wolfgang ^a   Freitag, Christine Margarete ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956135665     PISSN: 16624874     EISSN: 16624882     Source Type: Book Series    
DOI: 10.1159/000258449     Document Type: Article

References (115)

1. Barkley RA, Murphy KR: Attention-Deficit Hyperactivity Disorder. A Clinical Workbook. New York, Guilford Publications, 1998.
2. Weiss G, Hechtman LT, Milroy T, Perlman: Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985;24:211-220.
3. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M: Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50:565-576.
4. Barkley RA: Major life activity and health outcomes associated with attention-deficit hyperactivity disorder. J Clin Psychiatry 2002;63(suppl 12):10-15.
5. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine J P, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402-409.
6. Faraone S V, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P: Molecular genetics if attention-deficit hyperactivity disorder. Biol Psychiatry 2005;57:1313-1323.
7. Comings DE, Chen TJ, Blum K, Mengucci JF, Blum SH, Meshkin B: Neurogenetic interactions and aberrant behavioral co-morbidity of attention-deficit hyperactivity disorder: dispelling myths. Theor Biol Med Model 2005;2:50-65.
8. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders (Text Revision), ed 4. Washington, APA, 2000.
9. World Health Organization: International Statistical Classification of Diseases and Health-Related Problems. ICD-10, ed 2. Geneva, WHO, 1990.
10. Biederman J, Faraone S V, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, et al: Further evidence for family-genetic risk factors in attention-deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992;49:728-738.
11. Faraone S V, Biederman J, Chen WJ, Milberger S, Warburton R, Tsuang MT: Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol 1995;104:334-345.
12. Faraone S V, Biederman J, Mennin D, Russell R, Tsuang MT: Familial subtypes of attention-deficit hyperactivity disorder: a 4-year follow-up study of children from antisocial ADHD families. J Child Psychol Psychiatry 1998;39:1045-1053.
13. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MachPhie IL, Newbury DF, Crawford LR, Palmer CGS, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco A P, Smalley SL: A genomewide scan for loci involved in attentiondeficit hyperactivity disorder. Am J Hum Genet 2002;70:1183-1196.
14. Smalley SL, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, McGough JJ, McCracken JT, MacPhie IL, Francks C, Fisher SE, Cantor RM, Monaco A P, Nelson SF: Genetic linkage of attention-deficit hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet 2002;71:959-963.
15. Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG, Rapoport JL, Berg K, Bailey-Wilson JE, Muenke M: Attention-deficit hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 2004;75:998-1014.
16. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ, van t'Slot R, Minderaa RB, Gunning WB, Pearson PL, Sinke RJ: A whole-genome scan in 164 Dutch sib pairs with attention-deficit hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 2003;72:1251-1260.
17. Ogdie MN, MacPhie IL, Minassian SL, Yang M, Fisher SE, Francks C, Cantor RM, McCracken JT, McGough JJ, Nelson SF, Monaco A P, Smalley SL: A genomewide scan for attention-deficit hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet 2003;72:1268-1279.
18. Ogdie MN, Fisher SE, Yang M, Ishii J, Francks C, Loo SK, Cantor RM, McCracken JT, McGough JJ, Smalley SL, Nelson SF: Attention-deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet 2004;75:661-668.
19. Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M, Kiefl H, Remschmidt H, Hemminger U, Warnke A, Knölker U, Heiser P, Friedel S, Henney A, Schäfer H, Nürnberg P, Konrad K: A genome-wide scan for attention-deficit hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 2006;11:196-205.
20. Faraone S V, Doyle AE, Lasky-Su J, Sklar PB, D'Angelo E, Gonzalez-Heydrich J, Kratochvil C, Mick E, Klein K, Rezac AJ, Biederman J: Linkage analysis of attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1387-1391.
21. Asherson P, Zhou K, Anney RJ, Franke B, Buitelaar J, Ebstein R, Gill M, Altink M, Arnold R, Boer F, Brookes K, Buschgens C, Butler L, Cambell D, Chen W, Christiansen H, Feldman L, Fleischman K, Fliers E, Howe-Forbes R, Goldfarb A, Heise A, Gabriëls I, Johansson L, Lubetzki I, Marco R, Medad S, Minderaa R, Mulas F, Müller U, Mulligan A, Neale B, Rijsdijk F, Rabin K, Rommelse N, Sethna V, Sorohan J, Uebel H, Psychogiou L, Weeks A, Barrett R, Xu X, Banaschewski T, Sonuga-Barke E, Eisenberg J, Manor I, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Faraone SV: A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry 2008;13:514-521.
22. Romanos M, Freitag C, Jacob C, Craig DW, Dempfle A, Nguyen T T, Halperin R, Walitza S, Renner TJ, Seitz C, Romanos J, Palmason H, Reif A, Heine M, Windemuth-Kieselbach C, Vogler C, Sigmund J, Warnke A, Schäfer H, Meyer J, Stephan DA, Lesch KP: Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol Psychiatry 2008;13:522-530.
23. Amin N, Aulchenko YS, Dekker MC, Ferdinand RF, van Spreeken A, Temmink AH, Verhulst FC, Oostra BA, van Duijn CM: Suggestive linkage of ADHD to chromosome 18q22 in a young genetically isolated Dutch population. Eur J Hum Genet 2009; in press.
24. Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M, Freitag C, Seitz C, Palmason H, Scherag A, Windemuth-Kieselbach C, Schimmelmann BG, Wewetzer C, Meyer J, Warnke A, Lesch KP, Reinhardt R, Herpertz-Dahlmann B, Linder M, Hinney A, Remschmidt H, Schäfer H, Konrad K, Hübner N, Hebebrand J: Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol Psychiatry 2007;12:923-933.
25. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, Buitelaar J, Castellanos FX, Doyle A, Ebstein R P, Ekholm J, Forabosco P, Franke B, Freitag C, Friedel S, Gill M, Hebebrand J, Hinney A, Jacob C, Lesch KP, Loo SK, Lopera F, McCracken JT, McGough JJ, Meyer J, Mick E, Miranda A, Muenke M, Mulas F, Nelson SF, Nguyen TT, Oades RD, Ogdie MN, Palacio JD, Pineda D, Reif A, Renner TJ, Roeyers H, Romanos M, Rothenberger A, Schäfer H, Sergeant J, Sinke RJ, Smalley SL, Sonuga-Barke E, Steinhausen HC, van der Meulen E, Walitza S, Warnke A, Lewis CM, Faraone S V, Asherson P: Meta-analysis of genome-wide linkage scans of attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1392-1398.
26. Bobb AJ, Castellanos FX, Addington AM, Rapoport JL: Molecular genetic studies of ADHD: 1991-2004. Am J Med Genet B Neuropsychiatr Genet 2005;132:109-125.
27. Albayrak O, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J: Genetic aspects in attention-deficit hyperactivity disorder. J Neural Transm 2008;115:305-315.
28. Waldman ID, Gizer IR: The genetics of attentiondeficit hyperactivity disorder. Clin Psychol Rev 2006;26:396-432.
29. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG: Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999;283:397-402.
30. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR: Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000;22:133-139.
31. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl J P, Kosten TR, Innis RB, Gelernter J: Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000;157:1700-1703.
32. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ: Dopamine transporter density is elevated in patients with ADHD. Lancet 1999;354:2132-2133.
33. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K: Increased striatal dopamine transporter in adult patients with attention-deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000;285:107-110.
34. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL: Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56:993-998.
35. Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W, Nöthen MM, Grunhage F, Vandenbergh DJ, Uhl G, Sunohara G, King N, Kennedy JL: Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit hyperactivity disorder. Biol Psychiatry 2001;49:333-339.
36. Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, Greenwood T, Kelsoe J, Fitzgerald M, Gill M: Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 2003;8:299-308.
37. Palmer CG, Bailey JN, Ramsey C, Cantwell D, Sinsheimer JS, Del'Homme M, McGough J, Woodward JA, Asarnow R, Asarnow J, Nelson S, Smalley SL: No evidence of linkage or linkage disequilibrium between DAT1 and attention-deficit hyperactivity disorder in a large sample. Psychiatr Genet 1999;9:157-160.
38. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, Harrington R, McGuffin P, Owen M, Ollier W, Worthington J, Thapar A: A familybased and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention-deficit hyperactivity disorder. Mol Psychiatry 2000;5:523-530.
39. Roman T, Schmitz M, Polanczyk G V, Eizirik M, Rohde LA, Hutz MH: Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 2001;105:471-478.
40. Li D, Sham PC, Owen MJ, He L: Meta-analysis shows significant association between dopamine system genes and attention-deficit hyperactivity disorder. Hum Mol Genet 2006;15:2276-2284.
41. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM: Dopamine system genes and attention-deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002;12:207-215.
42. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, Huckett L, Sharp J, Batten C, Fernando S, Ozbay F, Yazgan Y, Simonoff E, Thompson M, Taylor E, Asherson P: Association study of a dopamine transporter polymorphism and attention-deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 2001;6:425-428.
43. Kirley A, Lowe N, Hawi Z, Mullins C, Daly G, Waldman I, McCarron M, O'Donnell D, Fitzgerald M, Gill M: Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet 2003;121:50-54.
44. Joober R, Grizenko N, Sengupta S, Amor LB, Schmitz N, Schwartz G, Karama S, Lageix P, Fathalli F, Torkaman-Zehi A, Stepanian MT: Dopamine transporter 3'-UTR VNTR genotype and ADHD: pharmaco-behavioural genetic study with methylphenidate. Neuropsychopharmacology 2007;32:1370-1376.
45. Stein MA, Waldman ID, Sarampote CS, Seymour KE, Robb AS, Conlon C, Kim SJ, Cook EH: Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology 2005;30:1374-1382.
46. Van der Meulen EM, Bakker SC, Pauls DL, Oteman N, Kruitwagen CL, Pearson PL, Sinke RJ, Buitelaar JK: High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sib pairs with ADHD. J Child Psychol Psychiatry 2005;46:1074-1080.
47. Mick E, Biederman J, Spencer T, Faraone SV, Sklar P: Absence of association with DST1 polymorphism and response to methylphenidate in a sample of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet 2006;141:890-894.
48. Barkley RA, Smith KM, Fischer M, Navia B: An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet 2006;141:487-498.
49. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 1996;12:78-80.
50. Durston S, Fossella JA, Casey BJ, Hulshoff Pol HE, Galvan A, Schnack HG, Steenhuis MP, Minderaa RB, Buitelaar JK, Kahn RS, van Engeland H: Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention-deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry 2005;10:678-685.
51. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL: Dopamine D4 receptor gene polymorphism is associated with attention-deficit hyperactivity disorder. Mol Psychiatry 1996;1:121-124.
52. Holmes J, Payton A, Barrett J, Harrington R, McGuffin P, Owen M, Ollier W, Worthington J, Gill M, Kirley A, Hawi Z, Fitzgerald M, Asherson P, Curran S, Mill J, Gould A, Taylor E, Kent L, Craddock N, Thapar A: Association of DRD4 in children with ADHD and comorbid conduct problems. Am J Med Genet 2002;114:150-153.
53. Gornick MC, Addington A, Shaw P, Bobb AJ, Sharp W, Greenstein D, Arepalli S, Castellanos FX, Rapoport JL: Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit hyperactivity disorder: an update. Am J Med Genet B Neuropsychiatr Genet 2007;144 B: 379-382.
54. Birkas E, Lakatos K, Nemoda Z, Ney K, Toth I, Novak A, Sasvari-Szekely M, Gervai J: Effects of the D4 dopamine receptor gene variation on behavior problems at 6 years of age (in Hungarian). Neuropsychopharmacol Hung 2005;7:125-131.
55. Grady DL, Chi HC, Ding YC, Smith M, Wang E, Schuck S, Flodman P, Spence MA, Swanson JM, Moyzis RK: High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry 2003;8:536-545.
56. Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z: Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: evidence of linkage and association with the SNP-616. Am J Med Genet B Neuropsychiatr Genet 2004;131:33-37.
57. Kereszturi E, Kiraly O, Csapo Z, Tarnok Z, Gadoros J, Sasvari-Szekely M, Nemoda Z: Association between the 120-bp duplication of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder: genetic and molecular analyses. Am J Med Genet B Neuropsychiatr Genet 2007;144 B: 231-236.
58. Faraone S V, Doyle AE, Mick E, Biederman J: Metaanalysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Psychiatry 2001;158:1052-1057.
59. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
60. Daly G, Hawi Z, Fitzgerald M, Gill M: Mapping susceptibility loci in attention-deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999;4:192-196.
61. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, Lee SY, Levy F, Kent L, Middle F, Rohde LA, Roman T, Tahir E, Yazgan Y, Asherson P, Mill J, Thapar A, Payton A, Todd RD, Stephens T, Ebstein R P, Manor I, Barr CL, Wigg KG, Sinke RJ, Buitelaar JK, Smalley SL, Nelson SF, Biederman J, Faraone S V, Gill M: Joint analysis of the DRD5 marker concludes association with attention-deficit hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 2004;74:348-356.
62. Tang Y, Buxbaum SG, Waldman I, Anderson GM, Zabetian C P, Kohnke MD, Cubells JF: A single nucleotide polymorphism at DBH, possibly associated with attention-deficit hyperactivity disorder, associates with lower plasma dopamine β-hydroxylase activity and is in linkage disequilibrium with two putative functional single nucleotide polymorphisms. Biol Psychiatry 2006;60:1034-1038.
63. Roman T, Schmitz M, Polanczyk G V, Eizirik M, Rohde LA, Hutz MH: Further evidence for the association between attention-deficit hyperactivity disorder and the dopamine β-hydroxylase gene. Am J Med Genet 2002;114:154-158.
64. Wigg K, Zai G, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL, Barr CL: Attention-deficit hyperactivity disorder and the gene for dopamine β-hydroxylase. Am J Psychiatry 2002;159:1046-1048.
65. Inkster B, Muglia P, Jain U, Kennedy JL: Linkage disequilibrium analysis of the dopamine β-hydroxylase gene in persistent attention-deficit hyperactivity disorder. Psychiatr Genet 2004;14:117-120.
66. Bhaduri N, Sinha S, Chattopadhyay A, Gangopadhyay PK, Singh M, Mukhopadhyay KK: Analysis of polymorphisms in the dopamine β-hydroxylase gene: association with attention deficit hyperactivity disorder in Indian children. Indian Pediatr 2005;42:123-129.
67. Barr CL, Kroft J, Feng Y, Wigg K, Roberts W, Malone M, Ickowicz A, Schachar R, Tannock R, Kennedy JL: The norepinephrine transporter gene and attentiondeficit hyperactivity disorder. Am J Med Genet 2002;114:255-259.
68. McEvoy B, Hawi Z, Fitzgerald M, Gill M: No evidence of linkage or association between the norepinephrine transporter gene polymorphisms and ADHD in the Irish population. Am J Med Genet 2002;114:665-666.
69. De Luca V, Muglia P, Jain U, Kennedy JL: No evidence of linkage or association between the norepinephrine transporter gene MnlI polymorphism and adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2004;124:38-40.
70. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch J P, Greenstein DK, Clasen LS, Sharp WS, Inoff-Germain G, Wavrant-De Vrieze F, Arcos-Burgos M, Straub RE, Hardy JA, Castellanos FX, Rapoport JL: Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 2005;134:67-72.
71. Xu X, Knight J, Brookes K, Mill J, Sham P, Craig I, Taylor E, Asherson P: DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention-deficit hyperactivity disorder: no evidence for association. Am J Med Genet B Neuropsychiatr Genet 2005;134:115-118.
72. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, Waldman ID, Blakely RD, Kim KS: A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci USA 2006;103:19164-19169.
73. Yang L, Wang YF, Li J, Faraone SV: Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry 2004;43:1154-1158.
74. Comings DE, Gade-Andavolu R, Gonzalez N, Blake H, Wu S, MacMurray JP: Additive effect of three noradrenergic genes (ADRA2a, ADRA2c, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Genet 1999;55:160-172.
75. Barr CL, Wigg K, Zai G, Roberts W, Malone M, Schachar R, Tannock R, Kennedy JL: Attentiondeficit hyperactivity disorder and the adrenergic receptors a1C and a2C. Mol Psychiatry 2001;6:334-337.
76. Xu C, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL, Barr CL: Linkage study of the a2A adrenergic receptor in attention-deficit hyperactivity disorder families. Am J Med Genet 2001;105:159-162.
77. Levitan RD, Masellis M, Basile VS, Lam RW, Jain U, Kaplan AS, Kennedy SH, Siegel G, Walker ML, Vaccarino FJ, Kennedy JL: Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention-deficit hyperactivity disorder in adult women with seasonal affective disorder. J Affect Disord 2002;71:229-233.
78. Roman T, Schmitz M, Polanczyk G V, Eizirik M, Rohde LA, Hutz MH: Is the a2A adrenergic receptor gene (ADRA2A) associated with attention-deficit hyperactivity disorder? Am J Med Genet B Neuropsychiatr Genet 2003;120:116-120.
79. Retz W, Retz-Junginger P, Supprian T, Thome J, Rösler M: Association of serotonin promoter gene polymorphism with violence: relation with personality disorders, impulsivity and childhood ADHD psychopathology. Behav Sci Law 2004;22:415-425.
80. Seeger G, Schloss P, Schmidt MH: Functional polymorphism within the promoter of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 2001;6:235-238.
81. Retz W, Thome J, Blocher D, Baader M, Rösler M: Association of attention-deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism. Neurosci Lett 2002;319:133-136.
82. Manor I, Eisenberg J, Tyano S, Sever Y, Cohen H, Ebstein R P, Kotler M: Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention-deficit hyperactivity disorder. Am J Med Genet 2001;105:91-95.
83. Zoroglu SS, Erdal ME, Alasehirli B, Erdal N, Sivasli E, Tutkun H, Savas HA, Herken H: Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention-deficit hyperactivity disorder. Neuropsychobiology 2002;47:17-20.
84. Beitchman JH, Davidge KM, Kennedy JL, Atkinson L, Lee V, Shapiro S, Douglas L: The serotonin transporter gene in aggressive children with and without ADHD and nonaggressive matched controls. Ann NY Acad Sci 2003;1008:248-251.
85. Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z, Kirley A, Lowe N, Fitzgerald M, Gill M, Craddock N: Evidence that variation at the serotonin transporter gene influences susceptibility to attention-deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol Psychiatry 2002;7:908-912.
86. Curran S, Purcell S, Craig I, Asherson P, Sham P: The serotonin transporter gene as a QTL for ADHD. Am J Med Genet B Neuropsychiatr Genet 2005;134:42-47.
87. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone SV: Association between polymorphisms in serotonin transporter gene and attention-deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 2007;144:14-19.
88. Cadoret RJ, Langbehn D, Caspers K, Troughton EP, Yucuis R, Sandhu HK, Philibert R: Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population. Compr Psychiatry 2003;44:88-101.
89. Kim SJ, Badner J, Cheon KA, Kim BN, Yoo HJ, Kim SJ, Cook E Jr, Leventhal BL, Kim YS: Family-based association study of the serotonin transporter gene polymorphisms in Korean ADHD trios. Am J Med Genet B Neuropsychiatr Genet 2005;139:14-18.
90. Xu X, Mill J, Chen CK, Brookes K, Taylor E, Asherson P: Family-based association study of serotonin transporter gene polymorphism in attentiondeficit hyperactivity disorder: no evidence for association in UK and Taiwanese samples. Am J Med Genet B Neuropsychiatr Genet 2005;139:11-13.
91. Langley K, Payton A, Hamshere ML, Pay HM, Lawson DC, Turic D, Ollier W, Worthington J, Owen MJ, O'Donovan MC, Thapar A: No evidence of association of two 5-HT transporter gene polymorphisms and attention-deficit hyperactivity disorder. Psychiatr Genet 2003;13:107-110.
92. Zhao AL, Su LY, Zhang YH, Tang BS, Luo XR, Huang CX, Su QR: Association analysis of serotonin transporter promoter gene polymorphism with ADHD and related symptomatology. Int J Neurosci 2005;115:1183-1191.
93. Heiser P, Dempfle A, Friedel S, Konrad K, Hinney A, Kiefl H, Walitza S, Bettecken T, Saar K, Linder M, Warnke A, Herpertz-Dahlmann B, Schäfer H, Remschmidt H, Hebebrand J: Family-based association study of serotonergic candidate genes and attention-deficit hyperactivity disorder in a German sample. J Neural Transm 2007;114:513-521.
94. Wigg KG, Takhar A, Ickowicz A, Tannock R, Kennedy JL, Pathare T, Malone M, Schachar R, Barr CL: Gene for the serotonin transporter and ADHD: no association with two functional polymorphisms. Am J Med Genet B Neuropsychiatr Genet 2006;141:566-570.
95. Zoroglu SS, Erdal ME, Erdal N, Ozen S, Alasehirli B, Sivasli E: No evidence for an association between the T102C and 1438 G/A polymorphisms of the serotonin 2A receptor gene in attention-deficit hyperactivity disorder in a Turkish population. Neuropsychobiology 2003;47:17-20.
96. Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, Basile VS, Beitchman J, Kennedy JL: Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention-deficit hyperactivity disorder. Mol Psychiatry 2000;5:537-541.
97. Hawi Z, Dring M, Kirley A, Foley D, Kent L, Craddock N, Asherson P, Curran S, Gould A, Richards S, Lawson D, Pay H, Turic D, Langley K, Owen M, O'Donovan M, Thapar A, Fitzgerald M, Gill M: Serotonergic system and attention-deficit hyperactivity disorder: a potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multicentre sample. Mol Psychiatry 2002;7:718-725.
98. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, Flierl L, Knolker U, Friedel S, Schäfer H, Gross C, Hebebrand J, Warnke A, Lesch KP: Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit hyperactivity disorder. Mol Psychiatry 2005;10:1126-1132.
99. Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z: Tryptophan hydroxylase-2 gene variants associated with ADHD. Mol Psychiatry 2005;10:944-949.
100. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Anney R, Franke B, Gill M, Ebstein R, Buitelaar J, Sham P, Campbell D, Knight J, Andreou P, Altink M, Arnold R, Boer F, Buschgens C, Butler L, Christiansen H, Feldman L, Fleischman K, Fliers E, Howe-Forbes R, Goldfarb A, Heise A, Gabriels I, Korn-Lubetzki I, Johansson L, Marco R, Medad S, Minderaa R, Mulas F, Muller U, Mulligan A, Rabin K, Rommelse N, Sethna V, Sorohan J, Uebel H, Psychogiou L, Weeks A, Barrett R, Craig I, Banaschewski T, Sonuga-Barke E, Eisenberg J, Kuntsi J, Manor I, McGuffin P, Miranda A, Oades RD, Plomin R, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Faraone SV, Asherson P: The analysis of 51 genes in DSM-IV combined type attention-deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 2006;11:934-953.
101. Sheehan K, Hawi Z, Gill M, Kent L: No association between TPH2 gene polymorphisms and ADHD in a UK sample. Neurosci Lett 2007;412:105-107.
102. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, Vasquez AA, Asherson P, Chen W, Banaschewski T, Buitelaar J, Ebstein R, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke E, Mulas F, Taylor E, Laird N, Lange C, Daly M, Faraone SV: Genome-wide association scan of attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1337-1344.
103. Lasky-Su J, Anney RJ, Neale BM, Franke B, Zhou K, Maller JB, Vasquez AA, Chen W, Asherson P, Buitelaar J, Banaschewski T, Ebstein R, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Taylor E, Daly M, Laird N, Lange C, Faraone SV: Genome-wide association scan of the time to onset of attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1355-1358.
104. Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Röser C, Nguyen TT, Craig D W, Romanos J, Heine M, Meyer J, Freitag C, Warnke A, Romanos M, Schäfer H, Walitza S, Reif A, Stephan DA, Jacob C: Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 2008;115:1573-1585.
105. Thapar A, Harrington R, McGuffin P: Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design. Br J Psychiatry 2001;179:224-229.
106. Langley K, Rice F, van den Bree MB, Thapar A: Maternal smoking during pregnancy as an environmental risk factor for attention-deficit hyperactivity disorder behaviour. A review. Minerva Pediatr 2005;57:359-371.
107. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ: Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 2002;288:728-737.
108. Blanz B, Schmidt MH, Esser G: Familial adversities and child psychiatric disorders. J Child Psychol Psychiat 1991;32:939-950.
109. Fergusson DM, Lynskey MT, Horwood LJ: Factors associated with continuity and changes in disruptive behaviour patterns between childhood and adolescence. J Abnorm Child Psychol 1996;24:533-553.
110. Rutter M: Psychosocial adversity and child psychopathology. Br J Psychiatry 1999;174:480-493.
111. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, Ablon S, Warburton R, Reed E: Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry 1995;52:464-470.
112. Khan RS, Khoury J, Nichols WC, Lanphear BP: Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive and oppositional behaviours. J Pediatr 2003;143:104-110.
113. Becker K, El-Faddagh M, Schmidt MH, Esser G, Laucht M: Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. J Pediatr. 2008;152:263-269.
114. Retz W, Freitag CM, Retz-Junginger P, Wenzler D, Schneider M, Kissling C, Thome J, Rösler M: A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: interaction with adverse childhood environment. Psychiatry Res 2008;158:123-131.
115. Müller DJ, Mandelli L, Serretti A, DeYoung CG, De Luca V, Sicard T, Tharmalingam S, Gallinat J, Muglia P, De Ronchi D, Jain U, Kennedy JL: Serotonin transporter gene and adverse life events in adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1461-1469.